ICD-10-CM code · FY2027
E10.3213 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral
BillableValid for claims as a specific diagnosis code
About E10.3213
EvidencePulse™by 2 Minute Medicine®
Go deeper into type 1 diabetes.
Ask about the latest evidence, the landmark trials or what guidelines recommend, with every study cited. No ads, no sponsored answers.
Coding notes for E10.3213
No notes of its own; the notes below apply from the codes above it.
7th character 3
bilateral
Also applies, from E10.32 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy
7th character
- One of the following 7th characters is to be assigned to codes in subcategory E10.32 to designate laterality of the disease:
Also applies, from E10 Type 1 diabetes mellitus
Includes Conditions this code covers.
- brittle diabetes (mellitus)
- diabetes (mellitus) due to autoimmune process
- diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction
- idiopathic diabetes (mellitus)
- juvenile onset diabetes (mellitus)
- ketosis-prone diabetes (mellitus)
Excludes1 Not coded here: never report these together with this code (use the code given instead).
- diabetes mellitus due to underlying condition (E08.-)
- drug or chemical induced diabetes mellitus (E09.-)
- gestational diabetes (O24.4-)
- hyperglycemia NOS (R73.9)
- neonatal diabetes mellitus (P70.2)
- postpancreatectomy diabetes mellitus (E13.-)
- postprocedural diabetes mellitus (E13.-)
- secondary diabetes mellitus NEC (E13.-)
- type 2 diabetes mellitus (E11.-)
Chapter 4 notes (apply to every code in it)
Note
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Related codes in E10.321
- E10.3211 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eyeBillable
- E10.3212 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eyeBillable
- E10.3219 Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eyeBillable
Latest research on type 1 diabetes
- Finerenone improves albuminuria in adults with type 1 diabetes and chronic kidney disease
- Weekly insulin efsitora alfa is non-inferior to daily insulin degludec for reducing HbA1c in type 1 diabetes
- #VisualAbstract: Teplizumab Improves β-cell Function in Newly Diagnosed Type 1 Diabetes
- Baricitinib preserves beta cell function in new-onset type 1 diabetes
- Teplizumab effective in maintaining β-cell function in type 1 diabetes
2MM+
Read the research behind every diagnosis
2MM+ gives you every study summary in full, Classics downloads of the landmark trials, EvidencePulse and HypeCheck, and ad-free reading.
See 2MM+ plansICD-10-CM FY2027 code set, as published by the CDC National Center for Health Statistics (NCHS) and CMS, effective October 1, 2026 to September 30, 2027. Codes, titles and notes are shown as published. Check payer rules and the official guidelines before billing. This page is not medical advice.
Get the app